Rafael Díaz

机构：Estudios Clínicos Latinoamérica, Instituto Cardiovascular de Rosario · ORCID：0000-0003-2181-9579

发表论文 380 篇 · 总被引 79378 次 · h-index 112

代表论文

• Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT) (2024 · Diabetes Care · 被引 55)
• Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF (2024 · Journal of the American College of Cardiology · 被引 48)
• Tobacco use and risk of acute stroke in 32 countries in the INTERSTROKE study: a case–control study (2024 · EClinicalMedicine · 被引 26)
• Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation (2024 · European Heart Journal - Cardiovascular Pharmacotherapy · 被引 24)
• Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study (2024 · Journal of clinical lipidology · 被引 24)
• Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES (2025 · Circulation · 被引 23)